IDEXX Laboratories stock rises 2.89% and outperforms competitors
Updated
Updated · MarketWatch · May 6
IDEXX Laboratories stock rises 2.89% and outperforms competitors
10 articles · Updated · MarketWatch · May 6
Shares closed at $579.23 on Wednesday, snapping a two-day losing streak as trading volume reached 661,802, above the 50-day average of 545,970.
The broader market rallied, with the S&P 500 up 1.46% to 7,365.12 and the Dow Jones Industrial Average gaining 1.24% to 49,910.59.
IDEXX still finished 24.77% below its 52-week high of $769.98, while Johnson & Johnson and Medtronic fell and Boston Scientific posted a marginal gain.
With strong growth but a high valuation, is IDEXX stock a brilliant investment or a dangerous bubble?
IDEXX stock is soaring, so why is its CEO selling millions in shares just before his departure?
Can IDEXX's AI-powered diagnostics outsmart the projected decline in overall veterinary patient visits?